Imidazoquinolines as dual lipid kinase and mTOR inhibitors

Details for Australian Patent Application No. 2011250672 (hide)

Owner Novartis AG

Inventors Brachmann, Saskia Maria; Finan, Peter; Fritsch, Christine; GarciaEcheverria, Carlos; Maira, Sauveur-Michael; Murphy, Leon; Nicklin, Paul Leslie

Agent Davies Collison Cave

Pub. Number AU-A-2011250672

Parent 2008218806

Filing date 9 November 2011

Wipo publication date 1 December 2011

International Classifications

A61K 31/4745 (2006.01)

A61P 7/00 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 27/02 (2006.01) Drugs for disorders of the senses

A61P 31/04 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 31/12 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 35/00 (2006.01) Antineoplastic agents

A61P 37/00 (2006.01) Drugs for immunological or allergic disorders

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

Event Publications

1 December 2011 Application Open to Public Inspection

  Published as AU-A-2011250672

1 December 2011 Complete Application Filed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011250673-Sealable storage container

2011250661-Location-aware emergency broadcast receiver